Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $438 | In Stock | |
5 mg | $987 | In Stock | |
10 mg | $1,380 | In Stock | |
25 mg | $1,980 | In Stock | |
50 mg | $2,770 | In Stock | |
100 mg | $3,730 | In Stock |
Description | Monalizumab is a novel immune checkpoint inhibitor targeting natural killer cell population 2A (NKG2A). Monalizumab is a humanized monoclonal antibody against NKG2A that induces IFN-γ production, thereby activating natural killer cell function. Monalizumab has antitumor activity and can be used to study neck squamous cell carcinoma (HNSCC). |
Cas No. | 1228763-95-8 |
Storage | store at low temperature store at -80°C |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.